China Pharma Holdings (CPHI) Receivables: 2009-2025
Historic Receivables for China Pharma Holdings (CPHI) over the last 17 years, with Sep 2025 value amounting to $355,789.
- China Pharma Holdings' Receivables fell 97.51% to $355,789 in Q3 2025 from the same period last year, while for Sep 2025 it was $42.1 million, marking a year-over-year decrease of 25.95%. This contributed to the annual value of $13.8 million for FY2024, which is 4.14% down from last year.
- According to the latest figures from Q3 2025, China Pharma Holdings' Receivables is $355,789, which was down 97.45% from $14.0 million recorded in Q2 2025.
- China Pharma Holdings' Receivables' 5-year high stood at $14.4 million during Q4 2023, with a 5-year trough of $275,244 in Q2 2023.
- Over the past 3 years, China Pharma Holdings' median Receivables value was $14.0 million (recorded in 2025), while the average stood at $9.1 million.
- In the last 5 years, China Pharma Holdings' Receivables surged by 4,982.61% in 2024 and then plummeted by 97.51% in 2025.
- Quarterly analysis of 5 years shows China Pharma Holdings' Receivables stood at $2.1 million in 2021, then crashed by 78.94% to $450,670 in 2022, then spiked by 3,106.00% to $14.4 million in 2023, then dropped by 4.14% to $13.8 million in 2024, then tumbled by 97.51% to $355,789 in 2025.
- Its last three reported values are $355,789 in Q3 2025, $14.0 million for Q2 2025, and $14.0 million during Q1 2025.